118 related articles for article (PubMed ID: 11986255)
1. Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.
Schmitz JL; Denny TN; Garcia A; Lathey JL;
Clin Diagn Lab Immunol; 2002 May; 9(3):525-9. PubMed ID: 11986255
[TBL] [Abstract][Full Text] [Related]
2. Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals.
Kolber MA; Saenz MO
Clin Diagn Lab Immunol; 2003 Sep; 10(5):757-63. PubMed ID: 12965900
[TBL] [Abstract][Full Text] [Related]
3. T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
Vyakarnam A; Matear PM; Cranenburg C; Michie C; Beverley PC; Wahren B; Gill SK; Weller I
Int Immunol; 1991 Oct; 3(10):939-47. PubMed ID: 1721834
[TBL] [Abstract][Full Text] [Related]
4. Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 in HIV-1 p24-activated whole blood cultures: relationship with the viral load in plasma.
Hober D; Benyoucef S; Chieux V; De Groote D; De La Tribonnière X; Bocket L; Lion G; Mouton Y; Wattré P
Scand J Immunol; 1999 Jul; 50(1):83-90. PubMed ID: 10404056
[TBL] [Abstract][Full Text] [Related]
5. Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjects.
Moss RB; Giermakowska W; Lanza P; Turner JL; Wallace MR; Jensen FC; Theofan G; Richieri SP; Carlo DJ
Viral Immunol; 1997; 10(4):221-8. PubMed ID: 9473153
[TBL] [Abstract][Full Text] [Related]
6. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
7. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
Ratto-Kim S; Garner RP; Kim JH; Jagodzinski LL; Michael NL; Paris R; Redfield RR; Birx DL
J Infect Dis; 2004 Jun; 189(11):1988-95. PubMed ID: 15143464
[TBL] [Abstract][Full Text] [Related]
8. Characterization of HIV-specific proliferative T cell responses in HIV-infected persons.
Zhang Y; Huber M; Weissbrich B; Voss G; Langmann P; Klinker H; Jassoy C
AIDS Res Hum Retroviruses; 2001 May; 17(7):623-9. PubMed ID: 11375058
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels.
Boritz E; Palmer BE; Wilson CC
J Virol; 2004 Nov; 78(22):12638-46. PubMed ID: 15507650
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of proliferative responses to HIV-1 antigen in chronically HIV-infected patients under antiretroviral therapy.
Mohm JM; Rump JA; Schulte-Mönting J; Schneider J
J Clin Virol; 2004 Jul; 30(3):239-42. PubMed ID: 15135742
[TBL] [Abstract][Full Text] [Related]
11. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.
Ohlsson-Wilhelm BM; Cory JM; Kessler HA; Eyster ME; Rapp F; Landay A
J Infect Dis; 1990 Nov; 162(5):1018-24. PubMed ID: 1977803
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
13. Specificity of binding of HIV-1 anti-p24 antibodies to CD4+ lymphocytes from HIV-infected subjects.
Cameron PU; Hunter SD; Jolley D; Sonza S; Mijch A; Crowe SM
Cytometry; 1998 Sep; 33(1):83-8. PubMed ID: 9725562
[TBL] [Abstract][Full Text] [Related]
14. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.
Imami N; Pires A; Hardy G; Wilson J; Gazzard B; Gotch F
J Virol; 2002 Sep; 76(18):9011-23. PubMed ID: 12186885
[TBL] [Abstract][Full Text] [Related]
15. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.
Musey LK; Krieger JN; Hughes JP; Schacker TW; Corey L; McElrath MJ
J Infect Dis; 1999 Aug; 180(2):278-84. PubMed ID: 10395840
[TBL] [Abstract][Full Text] [Related]
16. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
17. In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune).
Moss RB; Wallace MR; Lanza P; Giermakowska W; Jensen FC; Theofan G; Chamberlin C; Richieri SP; Carlo DJ
Clin Diagn Lab Immunol; 1998 May; 5(3):308-12. PubMed ID: 9605982
[TBL] [Abstract][Full Text] [Related]
18. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
[TBL] [Abstract][Full Text] [Related]
19. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
20. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.
van Baalen CA; Klein MR; Huisman RC; Dings ME; Kerkhof Garde SR; Geretti AM; Gruters R; van Els CA; Miedema F; Osterhaus AD
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1659-65. PubMed ID: 8760412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
